Филтриране по Last updated date SelectСледПредиFrom - To Дата Крайна дата This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionPRIMEProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Leave this field blank Filter Резултати (3799) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 11-14 November 2019 (updated) 15 November 2019NewsHumanData on medicines EMA confirms Xeljanz to be used with caution in patients at high risk of blood clots 15 November 2019Press releaseHumanMedicinesPharmacovigilanceReferrals Measures to minimise risk of serious side effects of multiple sclerosis medicine Lemtrada 15 November 2019Press releaseHumanMedicinesPharmacovigilanceReferrals First vaccine to protect against Ebola 14 November 2019Press releaseHumanMedicines Regulators’ advice can make a difference for faster patient access to highly innovative therapies 12 November 2019NewsCorporate ‘Regulatory science to 2025’: live broadcast of post-consultation workshop 11 November 2019NewsCorporate Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 5-7 November 2019 8 November 2019Press releaseVeterinaryData on medicines Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 28-31 October 2019 31 October 2019NewsHumanPharmacovigilanceQuality of medicinesReferrals EMA closed 1 November 2019 31 October 2019News Regulatory update - EMA encourages companies to submit type I variations for 2019 by end of November 2019 29 October 2019News 1 … 93 94 95 96 97 Page 97 of 380 98 99 100 101 … 380
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 11-14 November 2019 (updated) 15 November 2019NewsHumanData on medicines
EMA confirms Xeljanz to be used with caution in patients at high risk of blood clots 15 November 2019Press releaseHumanMedicinesPharmacovigilanceReferrals
Measures to minimise risk of serious side effects of multiple sclerosis medicine Lemtrada 15 November 2019Press releaseHumanMedicinesPharmacovigilanceReferrals
Regulators’ advice can make a difference for faster patient access to highly innovative therapies 12 November 2019NewsCorporate
‘Regulatory science to 2025’: live broadcast of post-consultation workshop 11 November 2019NewsCorporate
Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 5-7 November 2019 8 November 2019Press releaseVeterinaryData on medicines
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 28-31 October 2019 31 October 2019NewsHumanPharmacovigilanceQuality of medicinesReferrals
Regulatory update - EMA encourages companies to submit type I variations for 2019 by end of November 2019 29 October 2019News